Allison Dorval, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 11,000 shares at $3.37 ($37K) on 2024-06-13, disclosed to the SEC on 2024-06-17.
Scheduled sale ($37k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VERV | SELL | 2025-04-03 | $14K | — | Filing → |
| VERV | SELL | 2024-12-03 | $3K | — | Filing → |
| VERV | SELL | 2023-12-01 | $6K | — | Filing → |